CoChat

Artificial intelligence applications in the diagnosis and treatment of bacterial infections

Zhang, Xiaoyu, Zhang, Deng, Zhang, Xifan, Zhang, Xin · 2024 · Frontiers in Microbiology
Cited by 69

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

The diagnosis and treatment of bacterial infections in the medical and public health field in the 21st century remain significantly challenging. Artificial Intelligence (AI) has emerged as a powerful new tool in diagnosing and treating bacterial infections. AI is rapidly revolutionizing epidemiological studies of infectious diseases, providing effective early warning, prevention, and control of outbreaks. Machine learning models provide a highly flexible way to simulate and predict the complex mechanisms of pathogen-host interactions, which is crucial for a comprehensive understanding of the nature of diseases. Machine learning-based pathogen identification technology and antimicrobial drug susceptibility testing break through the limitations of traditional methods, significantly shorten the time from sample collection to the determination of result, and greatly improve the speed and accuracy of laboratory testing. In addition, AI technology application in treating bacterial infections, particularly in the research and development of drugs and vaccines, and the application of innovative therapies such as bacteriophage, provides new strategies for improving therapy and curbing bacterial resistance. Although AI has a broad application prospect in diagnosing and treating bacterial infections, significant challenges remain in data quality and quantity, model interpretability, clinical integration, and patient privacy protection. To overcome these challenges and, realize widespread application in clinical practice, interdisciplinary cooperation, technology innovation, and policy support are essential components of the joint efforts required. In summary, with continuous advancements and in-depth application of AI technology, AI will enable doctors to more effectivelyaddress the challenge of bacterial infection, promoting the development of medical practice toward precision, efficiency, and personalization; optimizing the best nursing and treatment plans for patients; and providing strong support for public health safety.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fmicb.2024.1449844

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 103

  1. Abbasi, 2022, Identification of vaccine targets & design of vaccine against SARS-CoV-2 coronavirus using computational and deep learning-based approaches, PeerJ, 10, e13380, 10.7717/peerj.13380 · DOI
  2. Abu-Aqil, 2023, Quick detection of Proteus and Pseudomonas in patients’ urine and assessing their antibiotic susceptibility using infrared spectroscopy and machine learning, Sensors (Basel), 23, 8132, 10.3390/s23198132 · DOI
  3. Alami, 2020, Organizational readiness for artificial intelligence in health care: insights for decision-making and practice, J. Health Organ. Manag., 35, 106, 10.1108/JHOM-03-2020-0074 · DOI · Paper page
  4. Baowaly, 2019, Synthesizing electronic health records using improved generative adversarial networks, J. Am. Med. Inform. Assoc., 26, 228, 10.1093/jamia/ocy142 · DOI · Paper page
  5. Baron, 2019, Clinical microbiology in Underresourced settings, Clin. Lab. Med., 39, 359, 10.1016/j.cll.2019.05.001 · doi:10.1016/j.cll.2019.05.001
  6. Beam, 2014, Bayesian neural networks for detecting epistasis in genetic association studies, BMC Bioinformatics, 15, 368, 10.1186/s12859-014-0368-0 · DOI
  7. Bilgin, 2024, Theranostics and artificial intelligence: new frontiers in personalized medicine, Theranostics, 14, 2367, 10.7150/thno.94788 · DOI · Paper page
  8. Burkovski, 2022, Host–pathogen interaction 3.0, Int. J. Mol. Sci., 23, 12811, 10.3390/ijms232112811 · doi:10.3390/ijms232112811
  9. Cherkaoui, 2019, Automated incubation and digital image analysis of chromogenic media using Copan WASPLab enables rapid detection of vancomycin-resistant Enterococcus, Front. Cell. Infect. Microbiol., 9, 379, 10.3389/fcimb.2019.00379 · DOI
  10. Ciccolini, 2014, Efficient surveillance for healthcare-associated infections spreading between hospitals, Proc. Natl. Acad. Sci. USA, 111, 2271, 10.1073/pnas.1308062111 · DOI
  11. Cisek, 2017, Phage therapy in bacterial infections treatment: one hundred years after the discovery of bacteriophages, Curr. Microbiol., 74, 277, 10.1007/s00284-016-1166-x · DOI · Paper page
  12. d’Humières, 2021, The potential role of clinical metagenomics in infectious diseases: therapeutic perspectives, Drugs, 81, 1453, 10.1007/s40265-021-01572-4 · DOI
  13. Dande, 2018, Acquaintance to artificial neural networks and use of artificial intelligence as a diagnostic tool for tuberculosis: a review, Tuberculosis (Edinb.), 108, 1, 10.1016/j.tube.2017.09.006 · DOI
  14. Deelder, 2022, A modified decision tree approach to improve the prediction and mutation discovery for drug resistance in Mycobacterium tuberculosis, BMC Genomics, 23, 46, 10.1186/s12864-022-08291-4 · doi:10.1186/s12864-022-08291-4
  15. Deneke, 2017, PaPrBaG: a machine learning approach for the detection of novel pathogens from NGS data, Sci. Rep., 7, 39194, 10.1038/srep39194 · DOI · Paper page
  16. Desruisseaux, 2024, Retrospective validation of MetaSystems’ deep-learning-based digital microscopy platform with assistance compared to manual fluorescence microscopy for detection of mycobacteria, J. Clin. Microbiol., 62, e0106923, 10.1128/jcm.01069-23 · DOI
  17. Deusenbery, 2021, Recent innovations in bacterial infection detection and treatment, ACS Infect. Dis., 7, 695, 10.1021/acsinfecdis.0c00890 · DOI · Paper page
  18. Dillard, 2023, Metabolic network models of the Gardnerella Pangenome identify key interactions with the vaginal environment, mSystems, 8, e0068922, 10.1128/msystems.00689-22 · DOI
  19. Dou, 2023, Rapid detection and analysis of Raman spectra of Bacteria in multiple fields of view based on image stitching technique, FBL, 28, 249, 10.31083/j.fbl2810249 · DOI
  20. Durmuş Tekir, 2013, PHISTO: pathogen–host interaction search tool, Bioinformatics, 29, 1357, 10.1093/bioinformatics/btt137 · DOI · Paper page
  21. Ekins, 2017, Machine learning and docking models for Mycobacterium tuberculosis topoisomerase I, Tuberculosis (Edinb.), 103, 52, 10.1016/j.tube.2017.01.005 · DOI
  22. Eldin, 2019, Limitations of diagnostic tests for bacterial infections, Med. Mal. Infect., 49, 98, 10.1016/j.medmal.2018.12.004 · doi:10.1016/j.medmal.2018.12.004
  23. Elemento, 2024, How artificial intelligence unravels the complex web of Cancer drug response, Cancer Res., 84, 1745, 10.1158/0008-5472.CAN-24-1123 · DOI
  24. Ernst, 2006, Bead-based flow Cytometric assays: a multiplex assay platform with applications in diagnostic microbiology, 427, 10.1007/0-387-32892-0_25 · DOI
  25. Fatsis-Kavalopoulos, 2020, CombiANT: antibiotic interaction testing made easy, PLoS Biol., 18, e3000856, 10.1371/journal.pbio.3000856 · DOI
  26. Fleming, 2022, ToxPi*GIS toolkit: creating, viewing, and sharing integrative visualizations for geospatial data using ArcGIS, J. Expo. Sci. Environ. Epidemiol., 32, 900, 10.1038/s41370-022-00433-w · DOI
  27. Gammel, 2021, Comparison of an automated plate assessment system (APAS Independence) and artificial intelligence (AI) to manual plate Reading of methicillin-resistant and methicillin-susceptible Staphylococcus aureus CHROMagar surveillance cultures, J. Clin. Microbiol., 59, e0097121, 10.1128/JCM.00971-21 · DOI
  28. Gao, 2022, Scenario prediction of public health emergencies using infectious disease dynamics model and dynamic Bayes, Futur. Gener. Comput. Syst., 127, 334, 10.1016/j.future.2021.09.028 · DOI
  29. Goodman, 2016, A clinical decision tree to predict whether a Bacteremic patient is infected with an extended-Spectrum β-lactamase-producing organism, Clin. Infect. Dis., 63, 896, 10.1093/cid/ciw425 · DOI · Paper page
  30. Goodswen, 2021, Machine learning and applications in microbiology, FEMS Microbiol. Rev., 45, fuab015, 10.1093/femsre/fuab015 · DOI · Paper page
  31. Gurvic, 2022, Data-driven derivation of molecular substructures that enhance drug activity in gram-negative Bacteria, J. Med. Chem., 65, 6088, 10.1021/acs.jmedchem.1c01984 · DOI
  32. Han, 2024, The application of knowledge-based clinical decision support systems to detect antibiotic allergy, Antibiotics (Basel), 13, 244, 10.3390/antibiotics13030244 · DOI
  33. Heinson, 2015, The promise of reverse vaccinology, Int. Health, 7, 85, 10.1093/inthealth/ihv002 · DOI
  34. Hellmich, 2017, Contact tracing with a real-time location system: a case study of increasing relative effectiveness in an emergency department, Am. J. Infect. Control, 45, 1308, 10.1016/j.ajic.2017.08.014 · DOI
  35. Hirosawa, 2023, Diagnostic accuracy of differential-diagnosis lists generated by generative Pretrained transformer 3 Chatbot for clinical vignettes with common chief complaints: a pilot study, Int. J. Environ. Res. Public Health, 20, 3378, 10.3390/ijerph20043378 · DOI · Paper page
  36. Ho, 2019, Rapid identification of pathogenic bacteria using Raman spectroscopy and deep learning, Nat. Commun., 10, 4927, 10.1038/s41467-019-12898-9 · DOI · Paper page
  37. Horvath, 2020, Machine-assisted interpretation of auramine stains substantially increases through-put and sensitivity of microscopic tuberculosis diagnosis, Tuberculosis (Edinb.), 125, 101993, 10.1016/j.tube.2020.101993 · DOI
  38. Howard, 2024, Antimicrobial learning systems: an implementation blueprint for artificial intelligence to tackle antimicrobial resistance, Lancet Digit. Health, 6, e79, 10.1016/S2589-7500(23)00221-2 · DOI
  39. Hsu, 2021, An automated and portable antimicrobial susceptibility testing system for urinary tract infections, Lab Chip, 21, 755, 10.1039/d0lc01315c · DOI
  40. Hummel, 2020, Just data? Solidarity and justice in data-driven medicine, Life Sci. Soc. Policy, 16, 8, 10.1186/s40504-020-00101-7 · DOI
  41. Jiang, 2022, Machine learning advances in microbiology: a review of methods and applications, Front. Microbiol., 13, 925454, 10.3389/fmicb.2022.925454 · DOI
  42. Keith, 2024, Predictive phage therapy for Escherichia coli urinary tract infections: cocktail selection for therapy based on machine learning models, Proc. Natl. Acad. Sci. USA, 121, e2313574121, 10.1073/pnas.2313574121 · DOI · Paper page
  43. Khanna, 2019, Ensemble technique for prediction of T-cell Mycobacterium tuberculosis epitopes, Interdiscip. Sci., 11, 611, 10.1007/s12539-018-0309-0 · doi:10.1007/s12539-018-0309-0
  44. Kleandrova, 2020, The QSAR paradigm in fragment-based drug discovery: from the virtual generation of target inhibitors to multi-scale modeling, Mini Rev. Med. Chem., 20, 1357, 10.2174/1389557520666200204123156 · DOI
  45. Kulshrestha, 2024, Bacteriophage therapy against ESKAPE bacterial pathogens: current status, strategies, challenges, and future scope, Microb. Pathog., 186, 106467, 10.1016/j.micpath.2023.106467 · DOI
  46. Laliwala, 2022, Simpler procedure and improved performance for pathogenic Bacteria analysis with a paper-based Ratiometric fluorescent sensor Array, Anal. Chem., 94, 2615, 10.1021/acs.analchem.1c05021 · doi:10.1021/acs.analchem.1c05021
  47. Lane, 2022, Machine learning models for Mycobacterium tuberculosis in vitro activity: prediction and target visualization, Mol. Pharm., 19, 674, 10.1021/acs.molpharmaceut.1c00791 · DOI
  48. Langford, 2024, Confronting the disruption of the infectious diseases workforce by artificial intelligence: what this means for us and what we can do about it, Open Forum Infect. Dis., 11, ofae053, 10.1093/ofid/ofae053 · DOI
  49. Larentzakis, 2021, Artificial intelligence (AI) in medicine as a strategic valuable tool, Pan Afr. Med. J., 38, 184, 10.11604/pamj.2021.38.184.28197 · DOI · Paper page
  50. Larsen, 2014, Using metabolomic and transportomic modeling and machine learning to identify putative novel therapeutic targets for antibiotic resistant pseudomonad infections, Annu. Int. Conf. IEEE Eng. Med. Biol. Soc., 2014, 314, 10.1109/EMBC.2014.6943592 · DOI
  51. Lesosky, 2011, Effect of patterns of transferring patients among healthcare institutions on rates of nosocomial methicillin-resistant Staphylococcus aureus transmission: a Monte Carlo simulation, Infect. Control Hosp. Epidemiol., 32, 136, 10.1086/657945 · DOI
  52. Li, 2023, Do infrared thermometers hold promise for an effective early warning system for emerging respiratory infectious diseases?, JMIR Form Res., 7, e42548, 10.2196/42548 · DOI
  53. Liu, 2021, Machine learning for identifying resistance features of Klebsiella pneumoniae using whole-genome sequence single nucleotide polymorphisms, J. Med. Microbiol., 70, 10.1099/jmm.0.001474 · DOI
  54. Lu, 2022, Identification of antibiotic resistance and virulence-encoding factors in Klebsiella pneumoniae by Raman spectroscopy and deep learning, Microb. Biotechnol., 15, 1270, 10.1111/1751-7915.13960 · DOI · Paper page
  55. Mandal, 2024, Findaureus: an open-source application for locating Staphylococcus aureus in fluorescence-labelled infected bone tissue slices, PLoS One, 19, e0296854, 10.1371/journal.pone.0296854 · DOI
  56. Mc Cord-De Iaco, 2023, Machine learning clinical decision support systems for surveillance: a case study on pertussis and RSV in children, Front. Pediatr., 11, 1112074, 10.3389/fped.2023.1112074 · DOI
  57. McGregor, 2006, Impact of a computerized clinical decision support system on reducing inappropriate antimicrobial use: a randomized controlled trial, J. Am. Med. Inform. Assoc., 13, 378, 10.1197/jamia.M2049 · DOI · Paper page
  58. Mintz, 2019, Introduction to artificial intelligence in medicine, Minim. Invasive Ther. Allied Technol., 28, 73, 10.1080/13645706.2019.1575882 · DOI · Paper page
  59. Nakar, 2022, Detection of multi-resistant clinical strains of E. coli with Raman spectroscopy, Anal. Bioanal. Chem., 414, 1481, 10.1007/s00216-021-03800-y · DOI
  60. Nguyen, 2018, Developing an in silico minimum inhibitory concentration panel test for Klebsiella pneumoniae, Sci. Rep., 8, 421, 10.1038/s41598-017-18972-w · DOI · Paper page
  61. Njage, 2019, Improving hazard characterization in microbial risk assessment using next generation sequencing data and machine learning: predicting clinical outcomes in shigatoxigenic Escherichia coli, Int. J. Food Microbiol., 292, 72, 10.1016/j.ijfoodmicro.2018.11.016 · DOI
  62. Oh, 2018, A generalizable, data-driven approach to predict daily risk of Clostridium difficile infection at two large academic health centers, Infect. Control Hosp. Epidemiol., 39, 425, 10.1017/ice.2018.16 · DOI · Paper page
  63. Ohkusu, 2000, Cost-effective and rapid presumptive identification of gram-negative bacilli in routine urine, pus, and stool cultures: evaluation of the use of CHROMagar orientation medium in conjunction with simple biochemical tests, J. Clin. Microbiol., 38, 4586, 10.1128/JCM.38.12.4586-4592.2000 · doi:10.1128/jcm.38.12.4586-4592.2000
  64. Paquin, 2022, Spatio-temporal based deep learning for rapid detection and identification of bacterial colonies through lens-free microscopy time-lapses, PLoS Digit. Health, 1, e0000122, 10.1371/journal.pdig.0000122 · DOI
  65. Pérez-Sancho, 2018, Rapid differentiation of Staphylococcus aureus subspecies based on MALDI-TOF MS profiles, J. Vet. Diagn. Invest., 30, 813, 10.1177/1040638718805537 · DOI
  66. Periasamy, 2014, Advanced light microscopy, Methods, 66, 121, 10.1016/j.ymeth.2014.03.011 · DOI
  67. Pfeiffer, 2015, Spatial and temporal epidemiological analysis in the big data era, Prev. Vet. Med., 122, 213, 10.1016/j.prevetmed.2015.05.012 · DOI · Paper page
  68. Qiu, 2024, PB-LKS: a python package for predicting phage-bacteria interaction through local K-mer strategy, Brief. Bioinform., 25, bbae010, 10.1093/bib/bbae010 · DOI
  69. Ramachandran, 2022, Integrating central nervous system metagenomics and host response for diagnosis of tuberculosis meningitis and its mimics, Nat. Commun., 13, 1675, 10.1038/s41467-022-29353-x · DOI
  70. Rapún-Araiz, 2023, In vitro modeling of polyclonal infection dynamics within the human airways by Haemophilus influenzae differential fluorescent labeling, Microbiol. Spectr., 11, e0099323, 10.1128/spectrum.00993-23 · DOI
  71. Rawal, 2021, Identification of vaccine targets in pathogens and design of a vaccine using computational approaches, Sci. Rep., 11, 17626, 10.1038/s41598-021-96863-x · DOI
  72. Rees, 2022, All that glitters is not gold: trustworthy and ethical AI principles, AI Ethics, 3, 1241, 10.1007/s43681-022-00232-x · DOI
  73. Rhodes, 2023, Machine learning to stratify methicillin-resistant Staphylococcus aureus risk among hospitalized patients with community-acquired pneumonia, Antimicrob. Agents Chemother., 67, e0102322, 10.1128/aac.01023-22 · DOI
  74. Rodrigues Lopes, 2022, Microscopy-based phenotypic profiling of infection by Staphylococcus aureus clinical isolates reveals intracellular lifestyle as a prevalent feature, Nat. Commun., 13, 7174, 10.1038/s41467-022-34790-9 · DOI
  75. Santa Maria, 2017, Linking high-throughput screens to identify MoAs and novel inhibitors of Mycobacterium tuberculosis Dihydrofolate reductase, ACS Chem. Biol., 12, 2448, 10.1021/acschembio.7b00468 · DOI
  76. Senescau, 2018, Innovative DendrisChips® Technology for a Syndromic Approach of in vitro diagnosis: application to the respiratory infectious diseases, Diagnostics (Basel), 8, 77, 10.3390/diagnostics8040077 · DOI
  77. Shen, 2018, An ontology-driven clinical decision support system (IDDAP) for infectious disease diagnosis and antibiotic prescription, Artif. Intell. Med., 86, 20, 10.1016/j.artmed.2018.01.003 · DOI
  78. Sherry, 2023, An ISO-certified genomics workflow for identification and surveillance of antimicrobial resistance, Nat. Commun., 14, 60, 10.1038/s41467-022-35713-4 · DOI · Paper page
  79. Stracy, 2022, Minimizing treatment-induced emergence of antibiotic resistance in bacterial infections, Science (New York, N.Y.), 375, 889, 10.1126/science.abg9868 · DOI · Paper page
  80. Tagliaferri, 2019, Fighting pathogenic Bacteria on two fronts: phages and antibiotics as combined strategy, Front. Cell. Infect. Microbiol., 9, 22, 10.3389/fcimb.2019.00022 · DOI · Paper page
  81. Tilton, 2019, Development of a risk prediction model for hospital-onset Clostridium difficile infection in patients receiving systemic antibiotics, Am. J. Infect. Control, 47, 280, 10.1016/j.ajic.2018.08.021 · DOI
  82. Ting Sim, 2023, Machine learning in medicine: what clinicians should know, Singapore Med. J., 64, 91, 10.11622/smedj.2021054 · DOI
  83. Váradi, 2017, Methods for the detection and identification of pathogenic bacteria: past, present, and future, Chem. Soc. Rev., 46, 4818, 10.1039/c6cs00693k · DOI · Paper page
  84. Viertel, 2014, Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens, J. Antimicrob. Chemother., 69, 2326, 10.1093/jac/dku173 · DOI · Paper page
  85. Villarroel, 2016, HostPhinder: a phage host prediction tool, Viruses, 8, 116, 10.3390/v8050116 · DOI · Paper page
  86. Volynets, 2022, Identification of dual-targeted Mycobacterium tuberculosis aminoacyl-tRNA synthetase inhibitors using machine learning. Future, Med. Chem., 14, 1223, 10.4155/fmc-2022-0085 · doi:10.4155/fmc-2022-0085
  87. Waddington, 2022, Exploiting genomics to mitigate the public health impact of antimicrobial resistance, Genome Med., 14, 15, 10.1186/s13073-022-01020-2 · DOI
  88. Walsh, 2023, Antimicrobial resistance: addressing a global threat to humanity, PLoS Med., 20, e1004264, 10.1371/journal.pmed.1004264 · DOI · Paper page
  89. Wang, 2020, Early detection and classification of live bacteria using time-lapse coherent imaging and deep learning, Light Sci. Appl., 9, 118, 10.1038/s41377-020-00358-9 · DOI · Paper page
  90. Wang, 2021, A large-scale investigation and identification of methicillin-resistant Staphylococcus aureus based on peaks binning of matrix-assisted laser desorption ionization-time of flight MS spectra, Brief. Bioinform., 22, bbaa138, 10.1093/bib/bbaa138 · DOI
  91. Wang, 2022, Deep learning model for multi-classification of infectious diseases from unstructured electronic medical records, BMC Med. Inform. Decis. Mak., 22, 41, 10.1186/s12911-022-01776-y · DOI
  92. Wells, 2021, Evaluating the usability and acceptability of a geographical information system (GIS) prototype to visualise socio-economic and public health data, BMC Public Health, 21, 2151, 10.1186/s12889-021-12072-1 · DOI
  93. Wieser, 2012, MALDI-TOF MS in microbiological diagnostics-identification of microorganisms and beyond (mini review), Appl. Microbiol. Biotechnol., 93, 965, 10.1007/s00253-011-3783-4 · DOI · Paper page
  94. Wilson, 2015, Diagnostic microbiology: the accelerating transition from culture-based to molecular-based methods, Am. J. Clin. Pathol., 143, 766, 10.1309/AJCPIC9GPLHCV1NT · doi:10.1309/ajcpic9gplhcv1nt
  95. Wong, 2023, Leveraging artificial intelligence in the fight against infectious diseases, Science, 381, 164, 10.1126/science.adh1114 · DOI · Paper page
  96. Yan, 2021, Application of machine learning for the prediction of etiological types of classic fever of unknown origin, Front. Public Health, 9, 800549, 10.3389/fpubh.2021.800549 · DOI
  97. Yi, 2019, Direct antimicrobial susceptibility testing of bloodstream infection on SlipChip, Biosens. Bioelectron., 135, 200, 10.1016/j.bios.2019.04.003 · DOI
  98. Ying, 2022, T-SPOT with CT image analysis based on deep learning for early differential diagnosis of nontuberculous mycobacteria pulmonary disease and pulmonary tuberculosis, Int. J. Infect. Dis., 125, 42, 10.1016/j.ijid.2022.09.031 · DOI
  99. Youn, 2022, Knowledge integration and decision support for accelerated discovery of antibiotic resistance genes, Nat. Commun., 13, 2360, 10.1038/s41467-022-29993-z · DOI
  100. Younes, 2020, Drosophila as a model organism in host-pathogen interaction studies, Front. Cell. Infect. Microbiol., 10, 214, 10.3389/fcimb.2020.00214 · DOI
  101. Yu, Direct prediction of carbapenem-resistant, carbapenemase-producing, and colistin-resistant Klebsiella pneumoniae isolates from routine MALDI-TOF mass spectra using machine learning and outcome evaluation, Int. J. Antimicrob. Agents, 61, 106799, 10.1016/j.ijantimicag.2023.106799 · DOI
  102. Yu, Prediction of methicillin-resistant Staphylococcus aureus and carbapenem-resistant Klebsiella pneumoniae from flagged blood cultures by combining rapid Sepsityper MALDI-TOF mass spectrometry with machine learning, Int. J. Antimicrob. Agents, 62, 106994, 10.1016/j.ijantimicag.2023.106994 · DOI
  103. Zhang, 2023, Rapid identification of carbapenem-resistant Klebsiella pneumoniae based on matrix-assisted laser desorption ionization time-of-flight mass spectrometry and an artificial neural network model, J. Biomed. Sci., 30, 25, 10.1186/s12929-023-00918-2 · DOI

Cited by

See all 69

Metadata

Authors
Zhang, X., Zhang, D., Zhang, X., & Zhang, X.
Venue
Frontiers in Microbiology
Published
2024-08-06
Volume
15
ISSN
1664-302X
Cited by
69
References
6

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.